What Agents Are Actually Telling Clients About AI in Medicare: The Faster-Approvals-Faster-Denials Split and the Prep Talk Every Producer Should Be Having Before AEP

Based on 895 answers from licensed Medicare agents responding to 15 related consumer questions about AI, algorithms, denials, appeals, and prior authorization on Medicare Agents Hub.

Your clients are going to ask about AI this AEP. Some already have.

Maybe it's the 68-year-old who saw a news segment about algorithms denying claims. Maybe it's the spouse who read something about Medicare Advantage plans using software to auto-reject prior authorizations. Either way, the question lands in your lap: "Is a computer going to decide whether I get my surgery?"

We pulled 895 answers from agents on Medicare Agents Hub who've already fielded versions of this question. The responses split into three distinct camps, and each one points to a different enrollment script. Where you land probably depends on how you position MA vs. Original Medicare in your practice. But regardless of your camp, you need a compliant, honest answer ready before October 15.

The three camps

Across 15 questions touching AI, claims processing, prior authorization, and denials, agents cluster into three groups. None of these positions is fringe. All three show up repeatedly, often from producers with decades of experience.

Camp 1: The optimists

These agents see AI as a net positive for claims processing. Faster turnaround. Fewer billing errors. Better fraud detection. The logic: if routine claims get auto-approved based on clean documentation, everyone wins. Providers get paid faster, beneficiaries see less lag between service and resolution, and the system spends less money chasing paperwork mistakes.

The optimist position isn't naive. Most agents in this camp acknowledge that AI will also increase scrutiny. But they frame that as a feature, not a bug. If the documentation is solid, the claim moves through faster. If it's not, the system catches it earlier instead of letting it snowball into a denial three months later.

Where this gets tricky: optimists tend to be less vocal about what happens when the AI gets it wrong. The assumption is that human oversight catches errors. Whether that assumption holds at scale is the question the next camp is asking.

Camp 2: The pessimists

This is the group that worries you. And they're not small.

These agents see AI in Medicare Advantage claims processing as a denial accelerator. The concern: algorithms that are optimized for cost containment will default to "no" on anything that doesn't fit a narrow pattern. Prior authorization requests get flagged. Complex cases get bounced. And the appeal workload lands on the patient and their agent, not the carrier.

That framing is blunt. And it's worth noting: it's opinion, not established fact. CMS has not confirmed that any MA plan uses AI to make coverage determinations without human oversight. But the concern is real enough that agents are already building it into how they position plans at enrollment.

Several agents in the corpus specifically flag the prior authorization process on MA plans as the pressure point. One producer put it plainly: AI could speed up claims or cause more automatic declines that would have to be appealed. Another noted that over 90% of Medicare Advantage plans likely use some form of algorithmic review already. The worry isn't that AI exists in the system. The worry is that it tips the balance toward denials without a proportional investment in making appeals easier.

Camp 3: The pragmatists

The third camp skips the debate entirely. Their position: AI is already here, the question is moot, and what matters is whether your clients know what to do when a claim gets denied, regardless of whether a human or an algorithm made the call.

Pragmatists are the ones most likely to fold the AI conversation into their existing enrollment workflow. They don't argue about whether AI is good or bad. They focus on documentation, appeal rights, and making sure clients understand that denials happen on every plan type (yes, including Original Medicare) and that the process for fighting them is well-defined.

This is probably the safest camp for compliance purposes. It doesn't make unsubstantiated claims about any specific plan or carrier. It doesn't scare clients away from MA. And it gives you a natural bridge into the value you provide post-enrollment, which is exactly where the agent's role in appeals becomes concrete.

The client script: handling "will an algorithm deny my care?"

This is the question. It's coming from news coverage, social media, and increasingly from adult children who are researching Medicare for their parents. You need a compliant answer that does three things:

1. Acknowledges the concern without inflating it. Clients deserve honesty. "Yes, insurance companies use technology to process claims" is accurate. "AI is denying all your claims" is not.
2. Separates the medical decision from the payment decision. Your doctor decides what care you need. The plan decides what it pays for. Those are two different decisions, and the patient has appeal rights when they disagree.
3. Stays within CMS marketing rules. You cannot disparage a specific plan or carrier. You cannot make unsubstantiated claims about how a plan processes claims. You can explain how prior authorization works across plan types and what appeal rights exist.

A script that threads these needles:

"Technology is changing how claims get reviewed on every type of plan, not just Medicare Advantage. What I focus on with my clients is making sure you understand what your plan covers, what requires prior authorization, and exactly what to do if a claim gets denied. That's where I come in after enrollment. If something gets denied, we work through the appeal together."

That script works because it doesn't pick a camp. It doesn't promise AI will make things better or worse. It positions you as the person who knows the process and will be there when it matters.

What not to say

Avoid: "Medicare Advantage uses AI to deny your claims." Even if you believe it, you can't substantiate it for a specific plan, and CMS marketing rules prohibit disparaging plans during enrollment conversations. The line between educating a client and steering them away from a plan type is thin, and compliance reviewers know where it is.

Avoid: "Original Medicare doesn't use algorithms." Original Medicare uses its own automated systems for claims processing (the Medicare Administrative Contractors run sophisticated review software). Framing it as "human-only" is inaccurate.

Avoid: "AI will make everything faster and better." Clients who hear that and then get a denial will remember exactly what you promised.

The pre-enrollment prep talk

Regardless of which camp you're in, the AI conversation creates a natural opening for something producers should be doing anyway: setting expectations about denials and appeals before enrollment, not after.

The agents who do this well in the corpus share a common pattern. They bring up denials proactively during the discovery conversation. Not as a scare tactic, but as part of explaining what their ongoing relationship looks like. The pitch: "I'm going to be here when something goes wrong. Here's what 'going wrong' can look like, and here's what we do about it."

What to cover in the prep talk

Prior authorization exists on MA plans, and sometimes on Original Medicare too. The prior authorization landscape is one of the most common sources of client frustration. Set the expectation early: some services require advance approval, and your office will help coordinate that with the provider.

Denials happen. They're not the end of the story. Walk clients through the basic appeal structure: organization determination, reconsideration by an independent review entity, Administrative Law Judge hearing, Medicare Appeals Council, federal court. Most cases resolve at level one or two. The appeal timeline and process are defined by CMS rules, not carrier discretion.

Peer-to-peer review is a tool your doctor has. When a prior authorization gets denied, the treating physician can request a peer-to-peer review with the plan's medical director. Agents across the corpus flag this as one of the most effective steps in reversing a denial, and one of the least known among beneficiaries.

Your role has limits. You can help a client understand the denial letter, identify the appeal deadline, and connect them with their provider's billing office. You cannot file medical documentation, argue medical necessity, or practice law. Being clear about this upfront builds trust and avoids the "why didn't you fix this?" call in February.

What producers should be watching in 2026

A few things are moving in the regulatory space that touch this conversation directly. None of these are predictions. They're items on CMS and OIG radar that could change the terrain by the time AEP kicks off.

CMS scrutiny of algorithmic prior authorization. CMS has signaled interest in how MA plans use automated systems in coverage determinations. The agency's focus has been on ensuring that algorithmic decisions comply with the same clinical criteria and timeline requirements that apply to human reviewers. If new guidance drops before AEP, it could change the way you talk about prior authorization on MA plans.

OIG attention on MA denial rates. The Office of Inspector General has published multiple reports examining MA plan denial patterns, including denials that were later overturned on appeal. The consistent finding: a meaningful percentage of initial denials don't hold up under review. This data point is useful in client conversations about the value of appealing, but be careful about citing specific percentages without verifying the most recent report.

AI in diagnostics is a separate conversation. Medicare is already covering certain AI-powered diagnostic tools (cardiac imaging, retinal scans, some cancer detection applications). Agents in the corpus note this as an area where AI is clearly additive. Don't let the claims-processing debate bleed into the diagnostics conversation. They're different use cases with different regulatory frameworks.

The agent value proposition gets stronger, not weaker. If AI does increase claim scrutiny (whether through faster denials or more prior authorization requirements), the agent who understands the appeal process becomes more valuable to the client. Multiple producers in the corpus make this point explicitly. The technology changes. The need for someone who knows how to guide a client through complexity does not.

Bringing it back to the enrollment conversation

The AI question is really a trust question. Clients are asking: can I count on my plan to pay for the care my doctor says I need?

That question existed before AI entered the picture. Prior authorization, medical necessity reviews, and claim denials have been part of Medicare Advantage since the program started. What AI changes is the speed and scale at which those decisions get made, and maybe (agents disagree) the direction they tilt.

Your job isn't to resolve that debate. Your job is to make sure your client knows three things: what their plan covers, what happens if something gets denied, and that you'll be the one helping them through it. If you can do that clearly and honestly, the AI question answers itself.